|
|
|
| Unlock the future of advanced therapy medicinal products and antibody-drug conjugates using advanced analytics at the 2025 ISPE Aseptic Conference, taking place March 17-18 in Washington D.C., United States and virtually. Breakout sessions and panel discussions will focus on the following tracks: Advanced Modalities; Advanced Therapy Medicinal Products (ATMPs); Case Studies; Filling Operations; Regulations and Pharma 4.0™; Sterility and Release. Learn more and register. |
|
|
|
|
By Dipak Mahajan and Sampatkumar Govind Donthula, MarketsandMarkets | Pharma and biotech companies are increasingly using inspection machines with advanced technologies, such as x-ray inspection, robotics, and more, to help them get ahead of the competition. | |
|
|
| How Recent Trends Impact Bringing Your Molecule To Market | Article | West Pharmaceutical Services, Inc. | With accelerated approval times, growing competition between drugs, and a shift from hospital to home care, you’re under pressure to develop a delivery device in parallel with your drug. |
|
|
| Enhancing Patient Adherence Through Autoinjector Access | Article | By Enrico Zanetti, Cristina Brinkmann, and Francisco Gonzalez, FUJIFILM Diosynth Biotechnologies | As autoinjectors evolve to accommodate a diverse array of chronic diseases, consider the impact of partnering with experienced device manufacturers and fill/finish providers. |
|
|
|
|
|
|
FOCUS ON DOWNSTREAM MANUFACTURING |
|
|
| mRNA Product Purification Process Strategies | Article | Cytiva | Impurities from IVT can induce undesired immune responses and negatively impact translation efficiency. Explore the pros and cons of each option for mRNA purification. |
|
|
|
| Getting More From Your Buffer Management Strategy | Case Study | Asahi Kasei Bioprocess | A drug manufacturer faced challenges in buffer management. By implementing innovative inline buffer formulation technology, they were able to save space, increase efficiency, and become more sustainable. |
|
|
|
| Immunoassays And Orthogonal Characterization | Article | By Alla Zilberman, Kerry Wooding, Jacob Stubbs, Jared Isaac, and Eric Bishop, Cygnus Technologies Inc. | Learn about host cell proteins (HCPs) along with how they are produced, their negative effects, how to identify HCPs in drug substances, and some technologies offering a solution for manufacturers. |
|
|
|
DOWNSTREAM MANUFACTURING SOLUTIONS |
|
|
|
|
| Connect With Bioprocess Online: |
|
|
|